thylaminomethyl-2-thiouridine (mnm5s2U) has been shown
to be important for reading frame maintenance in Escherichia
coli,15 and we have recently reported the structure of the
tRNA anticodon domain containing mnm5s2U.16 There is less
known about the eukaryotic modified nucleoside 5-car-
bomethoxymethyl-2-thiouridine (mcm5s2U) than its close
analogue mnm5s2U. An understanding of the biophysical and
structural effects of mcm5s2U is particularly important
because this nucleoside appears to be directly involved in
RNA and protein recognition during HIV-1 reverse tran-
scription initiation.17,18 The present study describes the
synthesis of protected nucleoside phosphoramidites of
mcm5s2U and 5-carbomethoxymethyluridine (mcm5U) and
describes their incorporation, along with pseudouridine, into
mixture of 2′- and 3′-TBS derivatives, which after chro-
matographic separation, isomerization of the 3′-TBS, and
subsequent chromatographic separation (repeated twice)
yielded the pure 2′-isomers 3a and 3b in 69% and 83%
yields, respectively. The 5′-DMT and 2′-TBS nucleosides
3a and 3b were then reacted with 2-cyanoethyl-N,N-
diisopropylchlorophosphoramidite for 3 h in the presence of
diisopropylethylamine with DMAP catalyst to afford phos-
phoramidites 4a and 4b in 75% and 88% yields, respectively.
The modified tRNALys,3 anticodon domain in Figure 1 was
synthesized using commercial PAC-protected phosphora-
the anticodon stem loop (ASL) domain of human tRNALys,3
.
The mcm5s2U and mcm5U nucleosides19 were prepared
in good yields by the coupling of the bis-silyl derivative of
5-carbomethoxymethyl-2-thiouracil and 5-carbomethox-
yuracil with 1-O-acetyl-2,3,5-tri-O-benzoyl-â-D-ribofuranose
following the procedure of Vorbruggen.20 The nucleoside
sugar protection and phosphoramidite synthesis follows a
standard literature protocol for RNA oligonucleotide chem-
istry (Scheme 1).21 The 5′-hydroxyl groups of 1a and 1b
Scheme 1
Figure 1. Secondary structure of the 17-nucleotide anticodon stem-
loop domain of human tRNALys,3. Structures of the modified
nucleosides at positions 34 and 39 (tRNA numbering) are shown.
The native human tRNA also has the hypermodified ms2t6A
nucleoside at position 37.
midites (Glen Research) and standard coupling chemistry21
with t-BuOOH oxidation.22-24 Trityl assays indicated >98%
coupling for all the phosphoramidites; this was verified by
HPLC and MALDI/MS of the crude deprotected RNA. The
deprotection was carried out by treating column-bound RNA
with 10% DBU in methanol for 12 h at 25 °C.25 After DBU/
methanol treatment, the RNA solution was dried and then
treated with Et3N‚3HF26 to remove the TBS ethers. The fully
deprotected RNA was then purified by HPLC,27 and MALDI-
MS was used to verify that the purified oligonucleotides had
the correct molecular weight. The presence of the correct
modified nucleosides was further verified by digesting the
RNA to mononucleosides and then analyzing the digest by
combined LC/MS28,29 (Supporting Information). The 1H
NMR spectrum in Figure 2 shows strong peaks at 13.20,
12.30, and 11.60 from the central base pairs of the stem.
were protected as their dimethoxytrityl ethers using DMT-
Cl to give compounds 2a and 2b in 80% and 68% yields,
respectively. Treatment of 2a and 2b with TBS-Cl gave a
(22) Jager, A.; Engels, J. Tetrahedron Lett. 1984, 25, 1437-1440.
(23) Hayakawa, Y.; Uchiyama, M.; Noyori, R. Tetrahedron Lett. 1986,
27, 4191-4194.
(15) Brierley, I.; Meredith, M. R.; Bloys, A. J.; Hagervall, T. G. J. Mol.
Biol. 1997, 270, 360-373.
(16) Sundaram, M.; Durant, P. C.; Davis, D. R. Biochemistry 2000, 39,
12575-12584.
(24) Kumar, R. K.; Davis, D. R. J. Org. Chem. 1995, 60, 7726-7727.
(25) Shah, K.; Wu, H.; Rana, T. M. Bioconjugate Chem. 1994, 5, 508-
512.
(17) Isel, C.; Ehresmann, C.; Keith, G.; Ehresmann, B.; Marquet, R. J.
Mol. Biol. 1995, 247, 236-250.
(26) Gasparutto, D.; Livache, T.; Bazin, H.; Dupla, A.; Guy, A.; Khordin,
A.; Molko, D.; Roget, A.; Teoule, R. Nucleic Acids Res. 1992, 20, 5159-
5166.
(27) Sproat, B.; Colonna, F.; Mulla, B.; Tsou, D.; Andrus, A.; Hampel,
A.; Vinayak, R. Nucleosides Nucleotides 1995, 14, 255-273.
(28) Crain, P. F. Methods Enzymol. 1990, 193, 782-790.
(29) Pomerantz, S. C.; McCloskey, J. A. Methods Enzymol. 1990, 193,
796-824.
(18) Isel, C.; Westhof, E.; Massire, C.; Le Grice, S. F. J.; Ehresmann,
B.; Ehresmann, C.; Marquet, R. EMBO J. 1999, 18, 1038-1048.
(19) Fissekis, J. D.; Sweet, F. Biochemistry 1970, 9, 3136-3142.
(20) Vorbruggen, H.; Strehlke, P. Chem. Ber. 1973, 106, 3039-3061.
(21) Wincott, F.; DiRenzo, A.; Shaffer, C.; Grimm, S.; Tracz, D.;
Workman, C.; Sweedler, D.; Gonzalez, C.; Scaringe, S.; Usman, N. Nucleic
Acids Res. 1995, 23, 2677-2684.
3866
Org. Lett., Vol. 2, No. 24, 2000